Hofseth BioCare (HBC) Cash Flow | TickerHofseth BioCare — Cash Flow
XOSL:HBC · OSLO BORS
| FY24 | FY23 | FY22 | FY21 | FY20 | YoY | Trend |
|---|
| Operating Activities |
| Profit Before Tax | -£125.3M | -£106.7M | -£137.4M | -£126.5M | -£102.1M | -17.4% | |
| Net Cash from Operating | -£9.8M | £2.8M | -£45.2M | -£61.8M | -£61.6M | -454.2% | |
| Investing Activities |
| Capital Expenditure | £2.4M | £8.2M | £4.0M | £22.9M | £32.6M | -70.2% | |
| Net Cash from Investing | -£4.1M | -£15.0M | -£17.8M | -£37.9M | -£60.1M | +72.8% | |
| Financing Activities |
| Share Issues | — | £0 | £70.8M | £0 | £245.6M | — | |
| Net Cash from Financing | £15.5M | £3.7M | £45.5M | -£23.2M | £200.0M | +320.7% | |
| Cash Movement |
| Net Change in Cash | £1.7M | -£8.5M | -£17.5M | -£122.9M | £78.3M | +119.7% | |
Currency: NOKPeriods: 5
Source: Annual Reports